Citigroup Lowers Petco Health and Wellness (NASDAQ:WOOF) Price Target to $3.25
Citigroup cut its Petco Health and Wellness (WOOF) price target to $3.25 from $4.00 and kept a “neutral” rating, according to a Thursday research note cited by Benzinga. WOOF traded at $2.82, down 7.6%. The article also notes Petco’s March 11 quarter: EPS -$0.01 vs $0.02 expected, revenue $1.52B vs $1.51B.
How this was made
The 30-second read
Why it matters
The immediate tradable element is the Citigroup target reduction to $3.25 (from $4.00) with a neutral rating, which can influence short-term positioning and expectations for the turnaround path.
Market read
WOOF faces a sentiment headwind from a fresh target cut, though the article also highlights mixed Street ratings and some positive turnaround signals.
What to watch
The piece also notes revenue/comps improvement and reaffirmed outlook; traders may discount target cuts if operating metrics continue to improve into the next earnings window.
Background
The article summarizes Citigroup’s downgrade in price target for Petco and provides context on other recent analyst actions plus recent trading/earnings details.
Ticker impact
Citigroup cut Petco’s price target to $3.25 and kept a neutral rating, signaling reduced upside expectations for WOOF shares.
Mild-to-moderate downside bias near term; upside likely capped unless fundamentals re-accelerate.
The article is specifically about a fresh analyst target reduction (Citigroup) and cites the stock’s recent drop and mixed earnings reaction, which together can sustain bearish positioning.
Market effects
Petco is a pet retail/healthcare turnaround story; target cuts can weigh on the broader specialty retail sentiment and read-through to turnaround names.
Primarily US small/mid-cap retail sentiment; limited direct regional spillover implied.
Low—this is company-specific sell-side repricing rather than a global macro shock.
Counterpoint
Other analysts in the article raised targets and upgraded to Buy, suggesting the Citigroup cut may be one of several competing narratives rather than a consensus deterioration.
Key entities
- companyPetco Health and Wellness
NASDAQ-listed pet specialty retailer; subject of the analyst price-target cut and recent earnings reaction.
- analyst_firmCitigroup
Issued the new $3.25 price target and neutral rating for Petco.
